Showing 790 – 800 of 1307 results
-
UK Best Companies to Work For Survey
William Blair was named a “Best Mid-Sized Company to Work For” in the UK in a Best Companies’ survey. The firm also was recognized as a best financial service organization.
-
Things Are Improving for Lower Income Consumers
In this Economics Weekly we take a look at the consumer, what’s happened with regard to the wealth inequality gap, and why some of the more recent economic data actually sheds a ray of hope that solid progress is being made in addressing this issue.
-
SPH Analytics and Press Ganey Transaction
William Blair acted as exclusive financial advisor to SPH Analytics, a portfolio company of Symphony Technology Group, in connection with its sale to Press Ganey.
-
People Corporation and Goldman Sachs Merchant Banking
William Blair acted as the financial advisor to People Corporation (TSX Venture: PEO) in connection with its pending take-private sale to Goldman Sachs Merchant Banking.
-
William Blair Names 24 New Partners
William Blair the premier global boutique with expertise in investment banking, investment management, and private wealth management, announced today it named 24 new partners worldwide this month.
-
Braming Named Influential Woman in Institutional Investing
Stephanie Braming, CFA, partner, and global head of William Blair Investment Management, was named an influential woman in institutional investing by Pensions & Investments.
-
American Landscaping Partners and Shoreline Equity Partners Transaction
William Blair acted as the exclusive financial advisor to American Landscaping Partners, a portfolio company of Cold Bore Capital, in connection with its sale to Shoreline Equity Partners.
-
CELLect Horizons Moving the Needle in Hematological Malignancies
Explore the latest advancements in CAR-T therapies from William Blair’s Equity Research healthcare and biotechnology team. Discover how these next-generation therapies are transforming the treatment landscape for patients with liquid tumors.
-
Updating FDA Approval Analysis for 2024 Data
Discover the latest insights in pharmaceutical outsourcing and services with our comprehensive analysis of FDA approvals for 2024. This report delves into the trends and key conclusions from a decade of data, highlighting the significant uptick in outsourcing penetration and the robust growth in biotech funding.
-
Trans Teens Captivate Latest Courageous Conversations
Champions of GenderCool, a national campaign that spotlights the remarkable stories of transgender youth, captured the hearts and minds of colleagues attending the latest William Blair Courageous Conversations.